BridgeMD
New treatment option for Aedes-borne Diseases
Official title Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes
ClinicalTrials.gov ID: NCT06981442
What this study is testing
- What it's testing
- Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health. In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- At household level:
- Belong to a household in one of the 4 health areas selected as study arms
- From 18 years of age to consent for household enrollment and participation in the serosurvey
- Consenting
You likely can't join if
- Not belong to a household in one of the 4 health areas selected as study arms
- Under 18 years of age
- Non-consenting At health facility level: Inclusion Criteria:
- From 18 years of age
- Resident of the health zone of Mont Ngafula 1
- Consenting Exclusion Criteria:
See the full eligibility criteria
- At household level:
- Belong to a household in one of the 4 health areas selected as study arms
- From 18 years of age to consent for household enrollment and participation in the serosurvey
- Consenting
- Not belong to a household in one of the 4 health areas selected as study arms
- Under 18 years of age
- Non-consenting At health facility level: Inclusion Criteria:
- From 18 years of age
- Resident of the health zone of Mont Ngafula 1
- Consenting Exclusion Criteria:
- Under 18 years of age
- Not resident in the health zone of Mont Ngafula 1
- Seriously ill and hospitalized, requiring transfusion, presence of blood clotting disorders, allergies resulting from injections, adverse events associated with previous blood sampling, pregnancy
- Non-consenting
The study team makes the final eligibility decision.
Where it's taking place
- Kinshasa, République Démocratique Du Congo, Democratic Republic of the Congo
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kinshasa, République Démocratique Du Congo, Democratic Republic of the Congo. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.